Safety and Exploratory Efficacy Study of SF0166 in the Treatment of Neovascular Age-Related Macular Degeneration (AMD)
Status:
Completed
Trial end date:
2017-06-26
Target enrollment:
Participant gender:
Summary
The primary purpose of this study is to evaluate the safety and exploratory efficacy of
SF0166 Topical Ophthalmic Solution in patients with Neovascular (wet) Age-related Macular
Degeneration (AMD).